EFFECTS OF TRIFLUOPERAZINE IN AGED DEPRESSED FEMALE PATIENTS
GEORGE W. BROOKS M.D.1, and
M. GLENN MACDONALD M.D.2
1 Assistant Professor of Clinical Psychiatry, University of Vermont College of Medicine, Burlington.
2 Clinical Associate in Medicine, University of Vermont College of Medicine, Burlington.
It would appear that the incidence and severity of Parkinsonism in this age group is so high that trifluoperazine should be used very cautiously. Occurrence of 1 very dramatic recovery and 3 cases of gratifying improvement suggest that trifluoperazine may be useful in cases of chronic depression resistant to more usual therapies.
